Literature DB >> 22799488

TNFR1 signaling is associated with backbone conformational changes of receptor dimers consistent with overactivation in the R92Q TRAPS mutant.

Andrew K Lewis1, Christopher C Valley, Jonathan N Sachs.   

Abstract

The widely accepted model for tumor necrosis factor 1 (TNFR1) signaling is that ligand binding causes receptor trimerization, which triggers a reorganization of cytosolic domains and thus initiates intracellular signaling. This model of stoichiometrically driven receptor activation does not account for the occurrence of ligand independent signaling in overexpressed systems, nor does it explain the constitutive activity of the R92Q mutant associated with TRAPS. More recently, ligand binding has been shown to result in the formation of high molecular weight, oligomeric networks. Although the dimer, shown to be the preligand structure, is thought to remain present within ligand-receptor networks, it is unknown whether network formation or ligand-induced structural change to the dimer itself is the trigger for TNFR1 signaling. In the present study, we investigate the available crystal structures of TNFR1 to explore backbone dynamics and infer conformational transitions associated with ligand binding. Using normal-mode analysis, we characterize the dynamic coupling between the TNFR1 ligand binding and membrane proximal domains and suggest a mechanism for ligand-induced activation. Furthermore, our data are supported experimentally by FRET showing that the constitutively active R92Q mutant adopts an altered conformation compared to wild-type. Collectively, our results suggest that the signaling competent architecture is the receptor dimer and that ligand binding modifies domain mobilities intrinsic to the receptor structure, allowing it to sample a separate, active conformation mediated by network formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22799488     DOI: 10.1021/bi3006626

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

2.  Open and closed conformations of the isolated transmembrane domain of death receptor 5 support a new model of activation.

Authors:  Andrew K Lewis; Zachary M James; Jesse E McCaffrey; Anthony R Braun; Christine B Karim; David D Thomas; Jonathan N Sachs
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

3.  Noncompetitive inhibitors of TNFR1 probe conformational activation states.

Authors:  Chih Hung Lo; Tory M Schaaf; Benjamin D Grant; Colin Kin-Wye Lim; Prachi Bawaskar; Courtney C Aldrich; David D Thomas; Jonathan N Sachs
Journal:  Sci Signal       Date:  2019-07-30       Impact factor: 8.192

4.  Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes.

Authors:  Simon Neumann; Jan Hasenauer; Nadine Pollak; Peter Scheurich
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.

Authors:  Nagamani Vunnam; Sophia Szymonski; Petra Hirsova; Gregory J Gores; Jonathan N Sachs; Benjamin J Hackel
Journal:  Biochemistry       Date:  2020-09-30       Impact factor: 3.162

6.  Death Receptor 5 Activation Is Energetically Coupled to Opening of the Transmembrane Domain Dimer.

Authors:  Nagamani Vunnam; Cecily Kristine Campbell-Bezat; Andrew K Lewis; Jonathan N Sachs
Journal:  Biophys J       Date:  2017-07-25       Impact factor: 4.033

7.  Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation.

Authors:  Tobias Piegeler; E Gina Votta-Velis; Farnaz R Bakhshi; Mao Mao; Graeme Carnegie; Marcelo G Bonini; David E Schwartz; Alain Borgeat; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2014-06       Impact factor: 7.892

8.  Quantitative single-molecule localization microscopy combined with rule-based modeling reveals ligand-induced TNF-R1 reorganization toward higher-order oligomers.

Authors:  Franziska Fricke; Sebastian Malkusch; Gaby Wangorsch; Johannes F Greiner; Barbara Kaltschmidt; Christian Kaltschmidt; Darius Widera; Thomas Dandekar; Mike Heilemann
Journal:  Histochem Cell Biol       Date:  2014-02-12       Impact factor: 4.304

9.  Conformational states of TNFR1 as a molecular switch for receptor function.

Authors:  Chih Hung Lo; Evan C Huber; Jonathan N Sachs
Journal:  Protein Sci       Date:  2020-01-31       Impact factor: 6.725

10.  Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity.

Authors:  Fabian Richter; Kirstin A Zettlitz; Oliver Seifert; Andreas Herrmann; Peter Scheurich; Klaus Pfizenmaier; Roland E Kontermann
Journal:  MAbs       Date:  2018-10-02       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.